Raffaele Baffa serves as Executive at ZIOPHARM ONCOLOGY INC, where they oversee executive responsibilities. Since joining the company, Raffaele Baffa has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on May 17, 2021 involved receiving (via award) 80,645 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| May 17, 2021 | ZIOP | $0 | Award | 80,645 | $N/A | Discretionary |
Raffaele Baffa currently holds 280,645 shares of ZIOPHARM ONCOLOGY INC (ZIOP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Raffaele Baffa has been a net neutral trader of ZIOP stock. They have purchased $0 and sold $0 worth of shares.
Raffaele Baffa's most recent insider trade was on May 17, 2021, when they sold 80,645 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted